Results 321 to 330 of about 3,206,200 (405)
Some of the next articles are maybe not open access.
Aggressive Pituitary Tumors or Localized Pituitary Carcinomas: Defining Pituitary Tumors
Expert Review of Endocrinology & Metabolism, 2016Pituitary tumors are common and exhibit a wide spectrum of hormonal, proliferative and invasive behaviors. Traditional classifications consider them malignant only when they exhibit metastasis. Patients who suffer morbidity and mortality from aggressive tumors classified as "adenomas" are denied support provided to patients with "cancers" and in many ...
Sylvia L, Asa, Shereen, Ezzat
openaire +3 more sources
Overview of the 2022 WHO Classification of Pituitary Tumors
Endocrine Pathology, 2022Sylvia L Asa, Ozgur Mete, Arie Perry
exaly +2 more sources
Current Opinion in Neurology, 2012
The aim of this article is to review current research in the treatment of pituitary tumors and summarize emerging medical, surgical and radiation-based therapies.Existing medical agents such as dopamine agonists and somatostatin ligand receptors are being used in novel combinations to achieve biochemical remission for pituitary tumors and reduce tumor ...
Gautam U, Mehta, John A, Jane
openaire +2 more sources
The aim of this article is to review current research in the treatment of pituitary tumors and summarize emerging medical, surgical and radiation-based therapies.Existing medical agents such as dopamine agonists and somatostatin ligand receptors are being used in novel combinations to achieve biochemical remission for pituitary tumors and reduce tumor ...
Gautam U, Mehta, John A, Jane
openaire +2 more sources
Current Treatment Options in Neurology, 2009
Pituitary adenomas are the most common intrasellar tumors. With the exception of prolactinomas, first-line treatment is almost always surgical. Prolactinomas are usually treated with dopamine agonists such as cabergoline or bromocriptine. Somatostatin analogues, such as octreotide and lanreotide, can be adjunctive to surgical therapy in acromegaly ...
Nestoras, Mathioudakis +1 more
openaire +2 more sources
Pituitary adenomas are the most common intrasellar tumors. With the exception of prolactinomas, first-line treatment is almost always surgical. Prolactinomas are usually treated with dopamine agonists such as cabergoline or bromocriptine. Somatostatin analogues, such as octreotide and lanreotide, can be adjunctive to surgical therapy in acromegaly ...
Nestoras, Mathioudakis +1 more
openaire +2 more sources
Clinics in Laboratory Medicine, 1984
The most frequent pituitary neoplasm is the adenoma, which can produce signs and symptoms owing to mass effects or secretion of pituitary hormones. The authors discuss these mass effects of pituitary tumors on the endocrine system and excess hormone secretion by pituitary adenomas.
J H, Howanitz, P J, Howanitz
openaire +2 more sources
The most frequent pituitary neoplasm is the adenoma, which can produce signs and symptoms owing to mass effects or secretion of pituitary hormones. The authors discuss these mass effects of pituitary tumors on the endocrine system and excess hormone secretion by pituitary adenomas.
J H, Howanitz, P J, Howanitz
openaire +2 more sources
Neurologic Clinics, 1985
Great strides have been made in the understanding of anatomy, physiology, pathology, diagnosis, and treatment of pituitary adenomas. The single greatest credit should probably be given to the rapid advancement in surgical techniques that ushered in a new era of multispecialty interest in the pituitary and its disorders.
openaire +2 more sources
Great strides have been made in the understanding of anatomy, physiology, pathology, diagnosis, and treatment of pituitary adenomas. The single greatest credit should probably be given to the rapid advancement in surgical techniques that ushered in a new era of multispecialty interest in the pituitary and its disorders.
openaire +2 more sources